SCHEMBL6232157

SCHEMBL6232157

CCC(=C(CC)c1ccc(OC)cc1)c1ccc(OC)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 3/20 1.00
SMN1; SMN2 Q16637 3/20 0.59
ESR1 P03372 2/20 0.59
KMT2A Q03164 2/20 0.59
HIF1A Q16665 2/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.57
PTGS2 P35354 2/20 0.56
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
NR3C1 P04150 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
FYN P06241 1/20 0.56
PGR P06401 1/20 0.56
CHRM2 P08172 1/20 0.56
ADRB1 P08588 1/20 0.56
CYP3A4 P08684 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL554921 1.00 NR1I2 (1.00) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL554922 1.00 NR1I2 (1.00) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL2277367 0.92 NR1I2 (0.84) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL2277370 0.92 NR1I2 (0.84) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL14070594 0.90 NR1I2 (0.81) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
Diethylstilbestrol Diphosphate SCHEMBL7617243 0.84 BLM (0.87) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL10780099 0.82 PTGS2 (0.76) NR1I2ESR1KMT2APTGS2MEN1
SCHEMBL21378219 0.82 NR1I2 (0.69) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL3809258 0.82 ESR1 (0.75) NR1I2SMN1; SMN2ESR1KMT2AHIF1A
SCHEMBL10777096 0.82 ESR1 (0.75) NR1I2SMN1; SMN2ESR1KMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113861517-B Konjac glucomannan porous composite membrane, preparation method and application thereof 云南中烟工业有限责任公司 2022-11-18 CN disclosed
CN-113861517-A Konjac glucomannan porous composite membrane, preparation method and application thereof 云南中烟工业有限责任公司 2021-12-31 CN disclosed
EP-1214055-B1 PHARMACEUTICAL GEL CONTAINING ACTIVE SUBSTANCES HEXAL AG (DE) 2005-05-04 EP disclosed
EP-1339397-B1 ABSORBING AGENTS AND COVER LAYER WHICH IS IMPERMEABLE TO ACTIVE SUBSTANCES AND WHICH CONTAINS CHANNEL-FORMERS OR REMOVABLE PROTECTIVE LAYER OF A TRANSDERMAL THERAPEUTIC SYSTEM HEXAL AG (DE) 2004-08-11 EP disclosed
EP-1339397-A2 ABSORBING AGENTS AND COVER LAYER WHICH IS IMPERMEABLE TO ACTIVE SUBSTANCES AND WHICH CONTAINS CHANNEL-FORMERS OR REMOVABLE PROTECTIVE LAYER OF A TRANSDERMAL THERAPEUTIC SYSTEM HEXAL AG (DE) 2003-09-03 EP disclosed
EP-1214055-A2 PHARMACEUTICAL GEL CONTAINING ACTIVE SUBSTANCES HEXAL AG (DE) 2002-06-19 EP disclosed
WO-2002045700-A2 ABSORBING AGENTS AND COVER LAYER WHICH IS IMPERMEABLE TO ACTIVE SUBSTANCES AND WHICH CONTAINS CHANNEL-FORMERS OR REMOVABLE PROTECTIVE LAYER OF A TRANSDERMAL THERAPEUTIC SYSTEM HEXAL AG (DE) 2002-06-13 WO disclosed
EP-1185246-A1 PHARMACEUTICAL COMPOSITION FOR INTRANASAL USE OF ACTIVE SUBSTANCES THAT ARE INSOLUBLE AND/OR HARDLY SOLUBLE IN WATER Klöcker, Norbert, Dr.med. (DE) 2002-03-13 EP disclosed
WO-2001097832-A1 PHARMACEUTICAL PREPARATIONS CONTAINING CYCLOSPORINES AND NEUTRAL OILS AUDIT INSTITUTE FOR MEDICAL SERVICES AND QUALITY ASSURANCE GMBH (DE) 2001-12-27 WO disclosed
WO-2001021153-A2 PHARMACEUTICAL GEL CONTAINING ACTIVE SUBSTANCES HEXAL AG (DE) 2001-03-29 WO disclosed
WO-2000074651-A1 PHARMACEUTICAL COMPOSITION FOR INTRANASAL USE OF ACTIVE SUBSTANCES THAT ARE INSOLUBLE AND/OR HARDLY SOLUBLE IN WATER HEXAL AG (DE) 2000-12-14 WO disclosed
US-4225734-A Process for producing symmetrical olefins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1980-09-30 US disclosed